Chromosomal aneuploidy in leukemic blast crisis: A potential source of error in interpretation of bone marrow engraftment analysis by VNTR amplification
M. Zhou et al., Chromosomal aneuploidy in leukemic blast crisis: A potential source of error in interpretation of bone marrow engraftment analysis by VNTR amplification, MOL DIAGN, 4(2), 1999, pp. 153-157
Background: Polymerase chain reaction (PCR) amplification of polymorphic mi
crosatellite or minisatellite DNA markers has proven to be a fast, sensitiv
e, and specific technique in post-transplantation monitoring of bone marrow
engraftment, as well as early detection of residual disease and relapse. D
eletion or amplification of chromosomal segments carrying marker loci, as c
an occur in leukemia and other hematologic malignancies, may result in loss
or increased dosage of marker alleles. Examination of these marker alleles
by PCR therefore may give aberrant results, which might lead to misinterpr
etation of bone marrow transplantation (BMT) engraftment studies.
Methods and Results: We report a case of chronic myelogenous leukemia treat
ed by BMT PCR amplification of the minisatellite at the apoB locus on chrom
osome 2 was used to monitor the donor bone marrow engraftment. The patient
experienced relapse in blast crisis with a near-haploid karyotype with loss
of recipient-specific apoB allele causing an aberrant PCR result for bone
marrow engraftment that mimicked full donor engraftment.
Conclusions: Loss or gain of polymorphic DNA markers because of chromosomal
losses or gains in some hematologic malignancies may affect the interpreta
tion of bone marrow engraftment studies by PCR. When choosing polymorphic m
arkers for such studies, it is important to avoid those that will be affect
ed by expected chromosomal alteration, if possible. In addition, any abbera
nt post-transplantation typing should prompt further investigation to rule
out the possibility of chromosomal aberration. Review of all pertinent labo
ratory studies is important to avoid misinterpretation of results from a si
ngle test for engraftment analysis.